Global Gmp Cell Therapy Consumables Market Top Major Players 2024, Forecast To 2033
8 Mar, 2024
The GMP cell therapy consumables market has witnessed exponential growth, with its size growing from $14.13 billion in 2023 to $18.25 billion in 2024, demonstrating a CAGR of 29.2%. This growth can be attributed to increasing investments in regenerative medicine, advancements in cell therapy research, and rising prevalence of chronic diseases. Moving forward, the market is expected to see further exponential growth, reaching $46.86 billion by 2028, with a CAGR of 26.6%. Expansion of cell therapy applications, regulatory support, and technological innovations are poised to drive this growth. Additionally, trends such as investments in manufacturing infrastructure and digitalization are anticipated to shape the market, alongside collaborations and partnerships aimed at enhancing cell processing and data integration for improved therapeutic outcomes.
Global GMP Cell Therapy Consumables Market Key Driver
The surge in drug discovery activities fuels the GMP cell therapy consumables market. Advancements in molecular biology, genetics, and high-throughput screening techniques revolutionize drug discovery, enabling better understanding of disease mechanisms and efficient drug candidate screening. In 2022, the FDA's Center for Drug Evaluation and Research approved 37 new drugs and therapeutic biological products in the United States, showcasing the momentum in drug discovery. Hence, the surge in drug discovery drives the growth of the GMP cell therapy consumables market.
Get A Free Sample Of The Global GMP Cell Therapy Consumables Market ReportGlobal GMP Cell Therapy Consumables Market Segments
The gmp cell therapy consumables market covered in this report is segmented –
1) Product:Kits, Reagents or Molecular biology reagents, Growth Factors or Cytokines and Interleukins, Other Products
2) Cell Therapy:NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies
3) Process:Cell Collection And Characterization or Sorting and Separation, Cell Culture and Expansion or Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution or Handling, Process Monitoring and Control or Readministration or Quality Assurance, Other Processes
4) End-Use:Clinical, Commercial, Research
By Geography: The countries covered in the gmp cell therapy consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the GMP cell therapy consumables market in 2023. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gmp cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major GMP Cell Therapy Consumables Industry Players
Thermo Fisher Scientific Inc.; Fresenius Kabi AG; Danaher Corporation; Merck KGaA; Asahi Kasei Corporation; GE HealthCare Technologies Inc.; Corning Incorporated; Avantor Inc.; Lonza Group AG; Terumo Corporation; Catalent Inc.; Sartorius AG; Bio-Techne Corp; Repligen Corporation; Miltenyi Biotec BV & Co KG; Genscript Biotech Corporation; Rentschler Biopharma SE; FUJIFILM Irvine Scientific Inc.; BioLegend Inc.; STEMCELL Technologies Inc.; BioLife Solutions Inc.; Abzena Ltd.; Sino Biological Inc.; ProBioGen AG; MaxCyte Inc.; PromoCell GmbH; PeproTech Inc.; Cellares Corp.; Wilson Wolf Corporation; Cellexus Ltd.
Get The Full Global GMP Cell Therapy Consumables Market Report
GMP Cell Therapy Consumables Market Overview
GMP cell therapy consumables refer to consumable products and goods produced under good manufacturing practices (GMP) guidelines for cell-based therapies. Consumables and tools for cell culture are made to help researchers grow new cells in culture media for gene therapy, vaccine manufacture, tissue culture, toxicity testing, and drug development.